← Open Payments lookup

JAMES MENGES: Open Payments

NPI 1427277300 · GAINESVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,431 in 104 payments from 14 companies in 2025. Trend: 2023 $1,319 · 2024 $1,581 · 2025 $2,431

Food & beverage: $2,319Education: $111
CompanyPaymentsAmount
Alkermes, Inc.16$539
ABBVIE INC.20$479
Teva Pharmaceuticals USA, Inc.10$258
Otsuka America Pharmaceutical, Inc.14$255
E.R. Squibb & Sons, L.L.C.10$170
Janssen Pharmaceuticals, Inc7$153
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$151
Neurocrine BioSciences, Inc.5$118
Vanda Pharmaceuticals Inc.5$106
Axsome Therapeutics, Inc.4$92

Products named: VRAYLAR, ARISTADA, ABILIFY ASIMTUFII, INVEGA SUSTENNA, COBENFY, CAPLYTA, INGREZZA, AUSTEDO XR.

Industry payments across FL — which companies pay providers there.